SPL 0.00% 9.7¢ starpharma holdings limited

Ann: DEP Docetaxel Trial Dose Exceeds Common Taxotere Dose Level, page-13

  1. 262 Posts.
    lightbulb Created with Sketch. 1
    The only way for it to not cause any adverse effects is for it to be delivered to the cancer and not the whole body. That is the whole point of targeted delivery. At the moment the drug goes through the whole body and is diluted, but by targeting it there is no waste. I am only pointing out what the plan from Starpharma has been from the start. I don't know if that has been achieved, or has it? Having said that it is still a good thing that has been done if they have removed the solvent part for now. But we don't know?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
0.000(0.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
9.8¢ 10.5¢ 9.6¢ $210.8K 2.098M

Buyers (Bids)

No. Vol. Price($)
1 30408 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 3523 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.